These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7237452

  • 21. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S, McGuire JJ, Rustum YM.
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K, Balzarini J, Sandvold ML, Myhren F, Martinsen M, De Clercq E, Fodstad O.
    Cancer Res; 1999 Jun 15; 59(12):2944-9. PubMed ID: 10383159
    [Abstract] [Full Text] [Related]

  • 23. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 15; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 24. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May 15; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 25. Effect of 4'-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice.
    Giuliani FC, Coirin AK, Rice MR, Kaplan NO.
    Cancer Treat Rep; 1981 May 15; 65(11-12):1063-75. PubMed ID: 7296552
    [Abstract] [Full Text] [Related]

  • 26. Assessing growth and response to therapy in murine tumor models.
    Reynolds CP, Sun BC, DeClerck YA, Moats RA.
    Methods Mol Med; 2005 May 15; 111():335-50. PubMed ID: 15911989
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
    Sigounas G, Sallah S, Sigounas VY.
    Cancer Lett; 2004 Oct 28; 214(2):171-9. PubMed ID: 15363543
    [Abstract] [Full Text] [Related]

  • 32. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y, Yoshimura K, Shin T, Verheul H, Hammers H, Sanni TB, Salumbides BC, Van Erp K, Schulick R, Pili R.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [Abstract] [Full Text] [Related]

  • 33. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ, Moyer JD, Suffness M, Harrison SD, Cysyk R, Hamilton TC, Plowman J.
    Cancer Res; 1994 Feb 01; 54(3):724-9. PubMed ID: 8306334
    [Abstract] [Full Text] [Related]

  • 34. [Pharmacokinetic approach to the improvement of clinical predictability in the preclinical test for antitumor agents].
    Inaba M.
    Gan To Kagaku Ryoho; 1991 Jul 01; 18(9):1449-56. PubMed ID: 1906701
    [Abstract] [Full Text] [Related]

  • 35. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.
    Cancer Res; 2000 Jun 15; 60(12):3232-8. PubMed ID: 10866316
    [Abstract] [Full Text] [Related]

  • 36. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
    Petrangolini G, Pratesi G, De Cesare M, Supino R, Pisano C, Marcellini M, Giordano V, Laccabue D, Lanzi C, Zunino F.
    Mol Cancer Res; 2003 Oct 15; 1(12):863-70. PubMed ID: 14573787
    [Abstract] [Full Text] [Related]

  • 37. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 15; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 38. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
    Li Y, Tang ZY, Wang L, Yao Z, Lu R, Xue Q, Gao DM, Chen J.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 17; 84(8):675-9. PubMed ID: 15130313
    [Abstract] [Full Text] [Related]

  • 39. Rotational stress reduces the effectiveness of antitumor drugs in mice.
    Giraldi T, Perissin L, Zorzet S, Rapozzi V.
    Ann N Y Acad Sci; 1994 Nov 25; 741():234-43. PubMed ID: 7825811
    [No Abstract] [Full Text] [Related]

  • 40. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
    Shyam K, Penketh PG, Loomis RH, Rose WC, Sartorelli AC.
    J Med Chem; 1996 Feb 02; 39(3):796-801. PubMed ID: 8576923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.